Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws
SIGA Technologies Inc. (SIGA)
US:NASDAQ Investor Relations:
investor.siga.com/investor-relations
Company Research
Source: GlobeNewswire
NEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of SIGA Technologies, Inc.(NASDAQ: SIGA) (“SIGA” or the “Company”) SIGA Technologies, Inc. operates as a commercial-stage pharmaceutical company. The Company offers oral formulation of an antiviral drug for the treatment of human smallpox disease caused by variola virus. The Company had been conducting a clinical trial to evaluate the efficacy and safety of TPOXX (aka tecovirimat) in the treatment of mpox in combination with standard of care. On August 15, 2024, the preliminary analysis of the PALM 007 clinical trial revealed that TPOXX had failed to achieve its primary endpoint. PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION Dr. Jay Varma, SIGA’s Chief Medical Officer and Executive Vice President, was fired fr
Show less
Read more
Impact Snapshot
Event Time:
SIGA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIGA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIGA alerts
High impacting SIGA Technologies Inc. news events
Weekly update
A roundup of the hottest topics
SIGA
News
- Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced [Yahoo! Finance]Yahoo! Finance
- Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox AnnouncedGlobeNewswire
- Siga Technologies (SIGA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]Yahoo! Finance
- SIGA Technologies Vs. Emergent BioSolutions: Product Portfolio And Future Outlook [Seeking Alpha]Seeking Alpha
SIGA
Sec Filings
- 12/13/24 - Form 8-K
- 12/10/24 - Form 8-K
- 11/8/24 - Form SC
- SIGA's page on the SEC website